Wider-than-Expected Loss at Avanir - Analyst Blog
5/9/2013 9:51:01 AM - Zacks.com
Avanir Pharmaceuticals Q2 13 Earnings Conference Call At 4:30 PM ET
5/8/2013 3:01:00 PM - RTT News
Positive CHMP Opinion for Avanir - Analyst Blog
5/1/2013 10:48:54 AM - Zacks.com
New Survey Increases Gas Estimate for Israel's Leviathan Reserve
5/1/2013 8:52:00 AM - Dow Jones Business News
Pre-Market Most Active for Apr 26, 2013 : NOK, QQQ, ASML, BAC, MTU, RESI, JCP, BCS, FB, AVNR, ZNGA, SPNC
4/26/2013 8:39:55 AM - NASDAQ.com News
Avanir Pharma Reveals Positive CHMP Opinion For NUEDEXTA Approval In Europe
4/26/2013 8:01:00 AM - RTT News
Acorda: A Biotech Company To Consider
4/13/2013 9:39:00 AM - Seeking Alpha
Anacor, Gates Foundation Collaborate - Analyst Blog
4/9/2013 6:10:26 PM - Zacks.com
Valeant: The Sole Suitor for Obagi - Analyst Blog
4/9/2013 3:09:09 PM - Zacks.com
Valeant Inks Deal with Actavis - Analyst Blog
4/8/2013 5:07:27 PM - Zacks.com
Pipeline Progresses at Shire - Analyst Blog
4/5/2013 5:10:47 PM - Zacks.com
More Bio Run-Up Ideas
4/3/2013 4:26:00 PM - Seeking Alpha
ArQule Regains ARQ 092 Rights - Analyst Blog
4/2/2013 6:20:01 PM - Zacks.com
Pernix Reports Loss in 4Q - Analyst Blog
3/21/2013 2:33:16 PM - Zacks.com
Avanir Pharmaceuticals To Present At ROTH Conference ; Webcast At 2:30 PM ET
3/20/2013 1:31:00 PM - RTT News
Data on Eli Lilly's Cialis - Analyst Blog
3/19/2013 6:47:37 PM - Zacks.com
Good News for Cadence Pharma - Analyst Blog
3/18/2013 5:45:50 PM - Zacks.com
Corcept's Loss Narrows in 4Q - Analyst Blog
3/14/2013 2:12:53 PM - Zacks.com
Detailed Results on Merck's Tredaptive - Analyst Blog
3/12/2013 6:10:01 PM - Zacks.com
Narrower-Than-Expected Loss at CADX in 4Q - Analyst Blog
3/12/2013 3:30:24 PM - Zacks.com
Positive Data on Eli Lilly's Livalo - Analyst Blog
3/12/2013 2:31:30 PM - Zacks.com
Pernix Completes Somaxon Buy - Analyst Blog
3/11/2013 6:29:33 PM - Zacks.com
MDCO's Cangrelor Impresses - Analyst Blog
3/11/2013 6:28:51 PM - Zacks.com
Setback for Impax, Shares Plunge - Analyst Blog
3/6/2013 6:55:01 PM - Zacks.com
Back to Neutral on Endo Health - Analyst Blog
3/6/2013 3:10:01 PM - Zacks.com
